Restore Clinical Study

The Restore clinical trial is researching a possible new gene therapy for people living with severe sickle cell disease.

WANT TO LEARN MORE ABOUT THE RESTORE CLINICAL TRIAL?

  1. Speak to your doctor
  2. See study details at www.clinicaltrials.gov (Trial Identifier: NCT04819841)
  3. Contact a study site
Download Patient Brochure

Sites Open for Enrollment

Palo Alto, California, United States, 94304
Lucile Packard Children's Hospital
Contact:
Intake Team
O: 650-723-0912
E: [email protected]

Future Sites to be Opened for Study Enrollment

Saint Louis, Missouri, United States, 63110
Washington University
Columbus, Ohio, United States, 43205
Nationwide Children’s Hospital
For more information or questions, contact the Restore study team: [email protected]

Copyright 2024 © Kamau Therapeutics, Inc. All Rights Reserved.